Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in HUMA — Humacyte, Inc.

CIK 73124 CHICAGO, IL
Back to HUMA Full portfolio

Position in HUMA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$356,047
-$386,863 QoQ
Shares Held
456,473
-62.7% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 163 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HUMA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. HUMA ranks #298 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in HUMA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $356,047 456,473
2026-03-31 $742,910 1,223,908
2025-12-31 $1,102,178 1,146,910
2025-09-30 $1,794,731 1,031,456
2025-06-30 $2,179,118 1,042,641
2025-03-31 $1,577,796 925,395
2024-12-31 $4,551,027 901,194
2024-09-30 $4,398,163 808,486
2024-06-30 $2,747,817 572,462
2024-03-31 $1,709,705 549,745
2023-12-31 $1,604,902 565,107
2023-09-30 $1,519,456 518,586
2023-06-30 $1,430,022 500,008
2023-03-31 $1,501,236 485,837
2022-12-31 $1,075,892 509,902
2022-09-30 $768,192 235,642
2022-06-30 $778,068 242,389
2022-03-31 $861,948 122,089
2021-12-31 $901,725 124,376